The successful management of obesity—a complex, chronic and relapsing disease—through sustainable weight loss interventions can greatly improve individuals’ overall health status and diminish the severity of concomitant diseases such as diabetes. This activity will provide an overview of obesity and diabetes that describes effective multi-interventional approaches to weight loss and, importantly, highlights the role of incorporated lifestyle changes in promoting the likelihood of weight loss success and improved health outcomes. The conversational style of this activity will encourage discussion around obesity-care planning and examine the factors that must be considered due to the chronic and relapsing characteristics of this disease.

This activity is designed to introduce the basic concepts of providing services to specialized children and youth populations. It will discuss the importance of interdisciplinary collaboration, including the role of child welfare workers and juvenile justice workers within those interdisciplinary teams. A basic overview of consent laws and required documentation for children in state custody will also be covered, along with state compliance regulations for professionals working with children involved in the child welfare and juvenile justice system.

Urinary tract infections (UTIs) are the most common infectious illness, particularly among individuals aged 65 years and older, and affect roughly 20% to 35% of women during their lifetime. UTIs contribute to 8 million ambulatory visits and 1 million hospitalizations annually in the US. This podcast will provide an overview of updated approaches to UTI detection, diagnosis and treatment; review common uropathogens; and highlight the distinctive challenges of UTIs related to infection characteristics and complications. Experts will share valuable insights through a discussion of evidence-based strategies to manage and prevent UTIs effectively.

TennCare, in collaboration with Optum Rx, developed a multimodal program focused on encouraging LAI antipsychotic utilization and improving outcomes for patients with schizophrenia. This E-newsletter will provide an overview of the program, including details regarding the benefits of LAI atypical antipsychotics and other available agents, a brief review of schizophrenia and potential clinical steps. Additional information regarding the retrospective drug utilization review process and the rationale for brand drug preference will also be highlighted.